Wela Strategies, Inc. Gilead Sciences, Inc. Transaction History

Wela Strategies, Inc.

$215 Million
Q2 2024

A detailed history of Wela Strategies, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wela Strategies, Inc. holds 5,672 shares of GILD stock, worth $478,886. This represents 0.18% of its overall portfolio holdings.

Number of Shares

5,672

Previous 5,406 4.92%

Holding current value

$478,886

Previous $395,000 1.52%

% of portfolio

0.18%

Previous 0.19%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$63.15 - $72.88 $16,797 - $19,386	266 Added 4.92%	5,672 $389,000
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $37,579 - $45,827	525 Added 10.76%	5,406 $395,000
Q4 2023 Jan 05, 2024	BUY	$73.27 - $83.09 $16,778 - $19,027	229 Added 4.92%	4,881 $395,000
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $4,510 - $4,920	61 Added 1.33%	4,652 $348,000
Q2 2023 Jul 11, 2023	BUY	$76.01 - $86.7 $1,444 - $1,647	19 Added 0.42%	4,591 $353,000
Q1 2023 Apr 10, 2023	SELL	$77.31 - $88.08 $65,249 - $74,339	-844 Reduced 15.58%	4,572 $379,000
Q4 2022 Jan 05, 2023	BUY	$62.32 - $89.47 $19,880 - $28,540	319 Added 6.26%	5,416 $465,000
Q3 2022 Oct 07, 2022	BUY	$59.54 - $68.01 $22,446 - $25,639	377 Added 7.99%	5,097 $314,000
Q2 2022 Jul 06, 2022	BUY	$57.72 - $65.01 $8,080 - $9,101	140 Added 3.06%	4,720 $292,000
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $15,696 - $19,669	271 Added 6.29%	4,580 $272,000
Q4 2021 Jan 10, 2022	BUY	$64.88 - $73.64 $8,564 - $9,720	132 Added 3.16%	4,309 $313,000
Q3 2021 Oct 13, 2021	SELL	$67.69 - $73.03 $3,113 - $3,359	-46 Reduced 1.09%	4,177 $292,000
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $8,885 - $9,709	140 Added 3.43%	4,223 $291,000
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $244,980 - $279,522	4,083 New	4,083 $264,000
Q4 2020 Jan 21, 2021	SELL	$56.65 - $64.55 $184,225 - $209,916	-3,252 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$62.1 - $78.08 $201,949 - $253,916	3,252 New	3,252 $205,000

Others Institutions Holding GILD

# of Institutions

1,880

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wela Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wela Strategies, Inc. with notifications on news.

Account

Wela Strategies, Inc. Gilead Sciences, Inc. Transaction History